Limited Interim Arrangements for Extended Half-Life Clotting Factor Products

At the request of Australian Governments, the NBA has entered into limited interim arrangements with two companies, Bioverativ and Shire, to provide temporary access to extended half-life (EHL) clotting factor products under NBA supply arrangements for a limited number of haemophilia A and B patients with high priority needs.

Further information can be found at here.